Discontinuation report MYLAN-SERTRALINE
| Report ID | 30356 |
| Drug Identification Number | 02242521 |
| Brand name | MYLAN-SERTRALINE |
| Common or Proper name | SERTRALINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | SERTRALINE |
| Strength(s) | 100MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100BT |
| ATC code | N06AB |
| ATC description | ANTIDEPRESSANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-02-01 |
| Actual discontinuation date | 2018-02-01 |
| Remaining supply date | 2018-02-01 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | Last lot 3052596 Expires 28-Feb-19. Resolved/Discontinued in ID 30359 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2018-02-15 | French | Compare |
| v7 | 2018-02-15 | English | Compare |
| v6 | 2018-02-02 | French | Compare |
| v5 | 2018-02-02 | English | Compare |
| v4 | 2018-02-01 | French | Compare |
| v3 | 2018-02-01 | English | Compare |
| v2 | 2017-11-23 | French | Compare |
| v1 | 2017-11-23 | English | Compare |
Showing 1 to 8 of 8